Welcome to
MENOPAUSE MATTERS IRISH PRACTITIONERS AREA.
The aim of this section of Menopause Matters is to help therapies to be chosen and adjusted appropriately when treatment is considered necessary, after full consideration of the individual's symptoms and likely benefits and risks of treatment. For many women, the first treatment choice will prove to be effective without side-effects but in others, several adjustments may be necessary. Menopause Matters, along with resources from the British Menopause Society, aims to facilitate this process.
For online menopause learning for healthcare professionals, access the range of eduction options at https://thebms.org.uk/education/principles-practice-of-menopause-care/
In particular, you can now sign up for the BMS Management of the Menopause Certificate, a comprehensive new BMS online education package. This in-depth menopause education should provide the HCP learner with everything that they need to treat 95% of patients who walk through their door, leaving on the 5% of patients with complex issues to be referred for specialist care.
Please note: The BMS Management of the Menopause Certificates is a new qualification that replaces the BMS PPMC Certificate. Trainees who are already registered for the BMS PPMC Certificate should complete their competency-based training to achieve certification.
https://thebms.org.uk/education/principles-practice-of-menopause-care/management-of-the-menopause-certificate/
Also available is IMPART at https://www.imsociety.org/imsimpart_register.php
Aimed at both primary care practitioners and hospital specialists, IMPART delivers evidence-based educational material to improve women’s health care around and after the menopause.
New option for treating osteoporosis after menopause - 8 August 2024
We welcome the announcement that the National Institute for Health and Care Excellence (NICE) has approved a new drug, Abaloparatide, for use by the NHS in England. It will be available to eligible patients within three months.
Abaloparatide increases bone density by stimulating the cells that make new bone and it has been recommended for patients at high risk of bone fractures. NICE estimates that it could benefit more than 14,000 women who have gone through menopause.
See the news article on the NICE website.
Menopause Matters Magazine and Information Cards
You can email us below to request Information Cards and magazines for distribution to your patients.
Please let us know the following information:
- Name
- Organisation Address
- Phone number
- If you're requesting cards
- If you're requesting a FREE copy of the Magazine
To bulk order the magazine, bulk ordering forms
Click to visit Post Reproductive Health (formerly Menopause International)